Free Trial

Genenta Science (GNTA) Stock Price, News & Analysis

Genenta Science logo
$3.40 +0.20 (+6.25%)
Closing price 02:57 PM Eastern
Extended Trading
$3.40 0.00 (0.00%)
As of 06:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Genenta Science Stock (NASDAQ:GNTA)

Key Stats

Today's Range
$3.25
$3.49
50-Day Range
$3.05
$5.01
52-Week Range
$2.74
$7.28
Volume
3,738 shs
Average Volume
4,396 shs
Market Capitalization
$62.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$25.00
Consensus Rating
Buy

Company Overview

Genenta Science Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
56th Percentile Overall Score

GNTA MarketRank™: 

Genenta Science scored higher than 56% of companies evaluated by MarketBeat, and ranked 496th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Genenta Science has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Genenta Science has received no research coverage in the past 90 days.

  • Read more about Genenta Science's stock forecast and price target.
  • Earnings Growth

    Earnings for Genenta Science are expected to decrease in the coming year, from ($0.93) to ($1.07) per share.

  • Price to Book Value per Share Ratio

    Genenta Science has a P/B Ratio of 4.59. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.05% of the float of Genenta Science has been sold short.
  • Short Interest Ratio / Days to Cover

    Genenta Science has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Genenta Science has recently increased by 1.52%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Genenta Science does not currently pay a dividend.

  • Dividend Growth

    Genenta Science does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.05% of the float of Genenta Science has been sold short.
  • Short Interest Ratio / Days to Cover

    Genenta Science has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Genenta Science has recently increased by 1.52%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Genenta Science has a news sentiment score of 1.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Genenta Science this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for GNTA on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Genenta Science insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    28.99% of the stock of Genenta Science is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 15.13% of the stock of Genenta Science is held by institutions.

  • Read more about Genenta Science's insider trading history.
Receive GNTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genenta Science and its competitors with MarketBeat's FREE daily newsletter.

GNTA Stock News Headlines

GNTA Genenta Science S.p.A.
New law could create $3.7 trillion tsunami.
During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.
Genenta Science announces EUR 20M financing to expand pipeline
See More Headlines

GNTA Stock Analysis - Frequently Asked Questions

Genenta Science's stock was trading at $4.35 on January 1st, 2025. Since then, GNTA stock has decreased by 21.8% and is now trading at $3.40.

Genenta Science (GNTA) raised $28 million in an IPO on Wednesday, December 15th 2021. The company issued 2,400,000 shares at $10.50-$12.50 per share.

Shares of GNTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genenta Science investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Adobe (ADBE), Arista Networks (ANET), PDD (PDD) and AppLovin (APP).

Company Calendar

Today
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GNTA
CIK
1838716
Fax
N/A
Employees
7
Year Founded
N/A

Price Target and Rating

High Price Target
$25.00
Low Price Target
$25.00
Potential Upside/Downside
+635.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.89
Quick Ratio
6.89

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.74 per share
Price / Book
4.59

Miscellaneous

Outstanding Shares
18,290,000
Free Float
12,988,000
Market Cap
$62.19 million
Optionable
Not Optionable
Beta
0.62
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:GNTA) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners